-
1
-
-
77949332406
-
Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: A secondary analysis from the JUPITER (Justification for the Use of Statins in Preventionan Intervention Trial Evaluating Rosuvastatin) trial
-
P.M. Ridker, J. MacFadyen, M. Cressman, and R.J. Glynn Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Preventionan Intervention Trial Evaluating Rosuvastatin) trial J Am Coll Cardiol 55 2010 1266 1273
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1266-1273
-
-
Ridker, P.M.1
MacFadyen, J.2
Cressman, M.3
Glynn, R.J.4
-
2
-
-
0037031061
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
-
Heart Protection Study Collaborative Group
-
Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
3
-
-
0037458229
-
Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency
-
M. Tonelli, L. Moye, F.M. Sacks, B. Kiberd, and G. Curhan Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency Ann Intern Med 138 2003 98 104
-
(2003)
Ann Intern Med
, vol.138
, pp. 98-104
-
-
Tonelli, M.1
Moye, L.2
Sacks, F.M.3
Kiberd, B.4
Curhan, G.5
-
4
-
-
20844462717
-
Effect of pravastatin on cardiovascular events in people with chronic kidney disease
-
M. Tonelli, C. Isles, and G.C. Curhan Effect of pravastatin on cardiovascular events in people with chronic kidney disease Circulation 110 2004 1557 1563
-
(2004)
Circulation
, vol.110
, pp. 1557-1563
-
-
Tonelli, M.1
Isles, C.2
Curhan, G.C.3
-
5
-
-
8144224441
-
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria
-
F.W. Asselbergs, G.F. Diercks, and H.L. Hillege Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria Circulation 110 2004 2809 2816
-
(2004)
Circulation
, vol.110
, pp. 2809-2816
-
-
Asselbergs, F.W.1
Diercks, G.F.2
Hillege, H.L.3
-
6
-
-
10744229858
-
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial
-
H. Holdaas, B. Fellstrom, and A.G. Jardine Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial Lancet 361 2003 2024 2031
-
(2003)
Lancet
, vol.361
, pp. 2024-2031
-
-
Holdaas, H.1
Fellstrom, B.2
Jardine, A.G.3
-
7
-
-
67649426365
-
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
-
S.D. Navaneethan, F. Pansini, and V. Perkovic HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis Cochrane Database Syst Rev 2009 CD007784
-
(2009)
Cochrane Database Syst Rev
-
-
Navaneethan, S.D.1
Pansini, F.2
Perkovic, V.3
-
8
-
-
22344458137
-
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
-
DOI 10.1056/NEJMoa043545
-
C. Wanner, V. Krane, and W. Marz Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 2005 238 248 (Pubitemid 41058323)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.3
, pp. 238-248
-
-
Wanner, C.1
Krane, V.2
Marz, W.3
Olschewski, M.4
Mann, J.F.E.5
Ruf, G.6
Ritz, E.7
-
9
-
-
67649644922
-
Rosuvastatin in patients undergoing hemodialysis
-
T.I. Kassimatis, and P.A. Konstantinopoulos Rosuvastatin in patients undergoing hemodialysis N Engl J Med 361 2009 93 author reply 945
-
(2009)
N Engl J Med
, vol.361
, pp. 93
-
-
Kassimatis, T.I.1
Konstantinopoulos, P.A.2
-
10
-
-
0141468244
-
Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
-
M.J. Sarnak, A.S. Levey, and A.C. Schoolwerth Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation 108 2003 2154 2169
-
(2003)
Circulation
, vol.108
, pp. 2154-2169
-
-
Sarnak, M.J.1
Levey, A.S.2
Schoolwerth, A.C.3
-
11
-
-
67349205850
-
The role of statins in chronic kidney disease (CKD): Friend or foe?
-
T.I. Kassimatis, and P.A. Konstantinopoulos The role of statins in chronic kidney disease (CKD): friend or foe? Pharmacol Ther 122 2009 312 323
-
(2009)
Pharmacol Ther
, vol.122
, pp. 312-323
-
-
Kassimatis, T.I.1
Konstantinopoulos, P.A.2
-
12
-
-
41449093519
-
Effects of statins in patients with chronic kidney disease: Meta-analysis and meta-regression of randomised controlled trials
-
G.F. Strippoli, S.D. Navaneethan, and D.W. Johnson Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials BMJ 336 2008 645 651
-
(2008)
BMJ
, vol.336
, pp. 645-651
-
-
Strippoli, G.F.1
Navaneethan, S.D.2
Johnson, D.W.3
-
13
-
-
55049121209
-
Statins in patients with chronic kidney disease: A double-edged sword?
-
T.I. Kassimatis, and P.A. Konstantinopoulos Statins in patients with chronic kidney disease: a double-edged sword? J Am Coll Cardiol 52 2008 1679
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 1679
-
-
Kassimatis, T.I.1
Konstantinopoulos, P.A.2
-
14
-
-
0037407617
-
Study of Heart and Renal Protection (SHARP)
-
C. Baigent, and M. Landry Study of Heart and Renal Protection (SHARP) Kidney Int 84 Suppl 2003 S207 S210
-
(2003)
Kidney Int
, vol.84
, Issue.SUPPL.
-
-
Baigent, C.1
Landry, M.2
|